The
Catalysis Laboratory at Merck was established in 2002 to discover
and develop asymmetric hydrogenation transformations for application
to the company’s pipeline. Twenty years later, it is safe to
say that not only was what now feels like that modest goal accomplished,
but many varied catalytic technologies have also emerged from this
group. Furthermore, the successes achieved locally have spawned an
array of further investments in catalytic manifolds and other enabling
technologies across industry and academia alike. Herein, we will take
a look back at the team’s humble origins, discuss the many
impacts that have been realized from that initial outlay, and provide
thoughts on future directions entering the team’s third decade.